Interestingly, our recent work demonstrated that while IL-6 is associated with lung cancer diagnosis in both EAs30 and AAs31, the effect size was considerably larger among AAs, which is further evidence that this IL-6/JAK2/STAT3 pathway is important among AAs. This evidence concerns the gene JAK2 and lung carcinoma.